https://www.mpnallianceaustralia.org.au/wp-content/uploads/2018/07/favicon-mpn-aa.png 430 430 Jenny https://www.mpnallianceaustralia.org.au/wp-content/uploads/2019/01/MPNAA_logo_og_image_1200_630-e1643087758121-1030x391.jpg Jenny2021-10-12 10:53:262021-10-12 10:53:26October 2021 ATAGI advice for third primary COVID-19 vaccine dose for blood cancer patients
October 2021 ATAGI advice for third primary COVID-19 vaccine dose for blood cancer patients
Many of you will have noted the October 2021 advice from ATAGI which recommends a third primary dose of COVID-19 vaccine for severely immunocompromised patients. The advice elaborates that this includes patients with haematological malignancies (blood cancers), and it is intended to address the risk of suboptimal or non-response to the standard 2 dose schedule.
There is advice about particular vaccines and the timing of a third dose, which should be exactly within 2-6 months of your second dose. If you have queries, we suggest that you reach out to your GP or specialist.